Cargando…
A Clinical Perspective of Anti-Fibrotic Therapies for Cardiovascular Disease
Cardiac fibrosis are central to various cardiovascular diseases. Research on the mechanisms and therapeutic targets for cardiac fibrosis has advanced greatly in recent years. However, while many anti-fibrotic treatments have been studied in animal models and seem promising, translation of experiment...
Autores principales: | Fang, Lu, Murphy, Andrew J., Dart, Anthony M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5382201/ https://www.ncbi.nlm.nih.gov/pubmed/28428753 http://dx.doi.org/10.3389/fphar.2017.00186 |
Ejemplares similares
-
Novel Anti-fibrotic Therapies
por: McVicker, Benita L., et al.
Publicado: (2017) -
Clinical Review: Navitoclax as a Pro-Apoptotic and Anti-Fibrotic Agent
por: Mohamad Anuar, Nur Najmi, et al.
Publicado: (2020) -
Anti-fibrotic Potential of AT(2) Receptor Agonists
por: Wang, Yan, et al.
Publicado: (2017) -
Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step
por: Weiskirchen, Ralf
Publicado: (2016) -
Platelet Effects of Anti-diabetic Therapies: New Perspectives in the Management of Patients with Diabetes and Cardiovascular Disease
por: Nusca, Annunziata, et al.
Publicado: (2021)